Related Experiment Video

Updated: May 19, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Oncolytic Vaccinia virus and radiotherapy in head and neck cancer

D Mansfield1, T Pencavel, J N Kyula

  • 1The Institute of Cancer Research, Divisions of Cancer Biology and Radiotherapy and Imaging, Targeted Therapy Team, London, UK. david.mansfield@icr.ac.uk

Oral Oncology
|August 29, 2012
PubMed
Abstract

Insights

Oncolytic Vaccinia virus combined with radiotherapy shows promise for head and neck cancer. This combination therapy enhances cell killing and improves tumor regression rates in preclinical studies.

Area of Science:

  • Oncolytic virotherapy
  • Radiation oncology
  • Head and neck cancer research

Background:

  • Attenuated Vaccinia virus oncolytic therapies are in clinical trials.
  • Investigating combinations of oncolytic viruses and radiotherapy is crucial for optimizing cancer treatment.

Purpose of the Study:

  • To assess the synergistic potential of combining oncolytic Vaccinia virus with radiotherapy.
  • To evaluate the efficacy of this combination in head and neck cancer models.

Main Methods:

  • In vitro studies on various head and neck cancer cell lines (HN3, HN5, CAL27, Detroit, SIHN5B, PJ41) to analyze cell killing, cell cycle, and apoptosis.
  • In vivo studies using head and neck xenografts in CD1 nude mice to assess the effects of Vaccinia virus and X-radiation.

Main Results:

  • Vaccinia virus demonstrated dose- and time-dependent cell killing in vitro, inducing S-phase arrest and apoptosis.
  • In vivo, Vaccinia virus injection led to xenograft stabilization and regression.
  • Combination therapy with radiation significantly enhanced cell death, caspase activity, and long-term tumor regression rates.

Conclusions:

  • The combination of oncolytic Vaccinia virus and radiotherapy shows significant potential for head and neck cancer treatment.
  • These findings support further clinical investigation of this combined therapeutic approach.

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...